AN ARCHETYPE FOR CLASSIFICATION AND COMPARISON OF HTA ACTIVITIES IN LATIN AMERICA
Author(s)
Skaltsa K1, Allen N2, Van Engen A3, Blogg K4
1Quintiles Consulting, Barcelona, Spain, 2Centre for Innovation in Regulatory Science, London, UK, 3Quintiles Consulting, Hoofddorp, The Netherlands, 4Quintiles Consulting, Reading, UK
OBJECTIVES: HTA processes are being implemented in Latin America in an effort for a more efficient resource allocation. The objective of this study was to explore the HTA environment and classify its diversity based on previously developed taxonomies. This enables the comparison within the region, as well as with other regions in which similar maps have been developed, such as Europe. METHODS: Two taxonomic groupings were used as described in Allen et al 2013 Health Policy 113; 305– 312. The first one is based on the position of a national HTA agency in relation to the position of the regulatory and the coverage body. The second set focuses on the key tasks performed by the HTA agency. The following countries were examined: Mexico, Cuba, Costa Rica, Colombia, Venezuela, Ecuador, Peru, Bolivia, Brazil, Uruguay, Argentina and Chile. No information on HTA activity could be identified for the rest of the countries on official websites or publications. RESULTS: Seven different archetypes were identified by combining different values of the two taxonomic sets in these twelve countries. There were two main groups identified: one consisting of Brazil, Cuba and Chile where the HTA and coverage decisions are performed by the same agency and regulatory is independent, and the other one consisting of Costa Rica, Venezuela, Peru and Bolivia where no HTA process was identified and external evaluations or decisions from reference countries are used to inform decisions. CONCLUSIONS: Although the landscape is expected to change in the coming years, this first high-level overview shows that currently, there is a high degree of heterogeneity in HTA processes in Latin America despite the fact that these countries tend to share expertise in various levels, with few countries following similar processes and a number of countries with no HTA bodies in place at any decision level.
Conference/Value in Health Info
2014-11, ISPOR Europe 2014, Amsterdam, The Netherlands
Value in Health, Vol. 17, No. 7 (November 2014)
Code
PHP234
Topic
Health Technology Assessment
Topic Subcategory
Decision & Deliberative Processes
Disease
Multiple Diseases